SHOW ME

PRESS
May 17, 2024

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Announce Winner of Inaugural 2024 Life Sciences Innovation Summit  

NEW YORK, May 17, 2024 — J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United …
PRESS
Apr 4, 2024

J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United AlSaqer Group Announce Finalists of the 2024 Life Sciences Innovation Summit in Abu Dhabi

NEW YORK, April 4, 2024 /PRNewswire/ — J.P. Morgan Asset Management’s Life Sciences Private Capital, Blue Horizon Advisors and …
PRESS
Mar 5, 2024

Patient Care America Announces Acquisition of Lyfebulb

Combining Resources to Create the Premier, Patient-Focused Renal Solutions Provider  POMPANO BEACH, Fla. and NEW YORK, March 5, 2024 /PRNewswire/ — Patient …
PRESS
Nov 16, 2023

J.P. Morgan Life Sciences Private Capital Partners with Blue Horizon Advisors to Fuel Early Stage Biotech and Innovative Drug Development in Abu Dhabi

Application Period Opens Today, November 16, 2023 NEW YORK, Nov. 16, 2023 /PRNewswire/ — J.P. Morgan Asset Management’s Life Sciences …
PRESS
Jul 14, 2023

Karin Hehenberger: Paying The Gift Of Life Forward
PRESS
Apr 4, 2023

Lyfebulb’s Karin Hehenberger, MD, PhD, Makes Inc.’s 2023 Female Founders List
PRESS
Jan 26, 2023

OstoBuddy and South Asian IBD Alliance Named Winners of Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease
PRESS
Jan 10, 2023

Lyfebulb Launches RareCancerLyfe, A Digital Platform to Support the Rare Cancer Community
PRESS
Nov 28, 2022

Westport Doctor named Runner-Up for Chris Klug Foundation Award
PRESS
Sep 20, 2022

Lyfebulb Seeks Applicants for the Global 2022 Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in IBD

NEW YORK September 20, 2022 — Lyfebulb, a patient-empowerment platform that connects patientswith industry experts to support …
PRESS
Sep 19, 2022

­Lyfebulb and Veloxis Pharmaceuticals Announce Finalists for 2022 Innovation Challenge in Organ Transplantation

NEW YORK and NORTH CAROLINA, September 19, 2022 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that connects patients with …
PRESS
Jul 26, 2022

Lyfebulb and Veloxis Pharmaceuticals Seek Applicants for the Global 2022 Innovation Challenge in Organ Transplantation

NEW YORK and CARY, N.C., July 26, 2022 /PRNewswire/ — Lyfebulb, a patient-empowerment platform that connects patients with industry experts to …